ACC Publishes Guidelines for Non-Statin Therapies

Save

The American College of Cardiology has released its expert consensus guidance regarding the use of non-statin therapies to lower cholesterol in high-risk patients.

Severe Psoriasis Associated with a Renal Disease Risk

Save

There have been several reports of psoriasis being linked to chronic renal disease in the literature. Another population-based study has also found a link between severe psoriasis and kidney disease. 

Treating OA Knee Effusions with Low-Dose Spironolactone

Save

Knee effusions in osteoarthritis are estimated to occur in 44% of patients, and more than half of these are painful.  Management of knee OA with effusions can be problematic given the treatment options and the high recurrence rate.

The Week in Review - 1 April 2016

Save

Highlights from this week on RheumNow.com

Opioid Use in Rheumatoid Arthritis

Save

Opioid use and abuse is at an all time high. Epidemiologic and public health analyses have led to greater stringency and attempts to limit use have adversely effected those with arthritis.

Baricitinib Benefits Refractory RA

Save

The small molecule oral JAK inhibitor baricitinib was effective for patients with highly refractory rheumatoid arthritis, a phase III study found.

Incidence of Psoriatic Arthritis Among Psoriasis Patients

Save

Researchers at the University of Toronto have prospectively studied a cohort of 464 psoriasis patients without a diagnosis of arthritis and followed them over 8 years to estimate the incidence and frequency of psoriatic arthritis (PsA). 

Antibiotics Fail to Treat Chronic Symptoms of Lyme Disease

Save

(Reuters Health) - Twelve weeks of antibiotic therapy proved ineffective at combating the long-term symptoms seen in some people who have had Lyme disease, a new test of 280 sufferers found. (Citation source http://buff.ly/1Rs21R5)

Drug Safety Bulletin - March 2016

Save

RheumNow is committed to reporting safety issues in our monthly Drug Safety Bulletins, wherein we will update you with reports of new, ongoing and resolved Drug Shortages that will affect rheumatology.   If you have suggestions or information about specific drug sho

1 in 2 Americans Have Musculoskeletal Conditions

Save

A recent report from the United States Bone and Joint Initiative (USBJI) estimates that 126.6 million Americans (one in two adults) are affected by a musculoskeletal (MSK) condition; a number on par with the number of Americans living with a chronic lung or heart conditions.

High Mortal Risk in Rheumatoid Arthritis Following Arthroplasty

Save

Rheumatoid arthritis (RA) is associated with an increased risk of myocardial infarction (MI) and post-MI fatality compared with the general population. At issue is whether this applies to those undergoing a surgical procedure.

Mediterranean Diet Reduces Hip Fracture Risk

Save

Eating a Mediterranean diet full of fruits, vegetables, fish, nuts, legumes and whole grains appears to be associated with a lower risk of hip fracture in women, although the actual risk reduction was small, according to a new study published online by JAMA Internal Medicine.

Biologics Are Safe When Used During Pregnancy in IBD

Save

This is a reposting of an earlier report on RheumNow that includes additional commentary from Dr. Sunada Kane, a gastroenterologist at the Mayo Clinic who specializes in both inflammatory bowel disease (IBD) and pregnancy. 

Week in Review - 25 March 2016

Save

1. phase 3, BRIDGE study shows romosozumab (anti-sclerostin MAb) significantly increases lumbar BMD in men with osteoporosis


2. Statin use is associated with a 21% increased risk of skin cancer (NMSC) - data

The Increasing and Disappointing P Value

Save

In the March 15th issue of JAMA, Chavalarias and coworkers describe the evolution of the “P value” and its use in biomedical research in the last 25 years.  (CItation Source http://buff.ly/22L0pG7)

DMARDs Combo Cuts Time to First Remission in RA

Save

A three-therapy protocol did not prove superior for achieving remission in rheumatoid arthritis (RA) patients after 1 year, but the regimen did lead to a shorter time until first remission versus a step-up approach, according to an analysis of the DREAM registry.

Increasing Polypharmacy and Drug Interactions in Seniors

Save

Qato and colleagues have published in JAMA a cohort study that examined the use of both prescription and over-the-counter medications among older adults and the frequency of major drug-drug interactions. The study shows the elderly are especially at risk, and the situation is

First Head-to-Head TNF Trial Ends in a Draw

Save

Comparative efficacy trials may be the best way to make informed treatment choices in a sea of treatment options for rheumatoid arthritis (RA).  Recent years have seen impressive head-to-head (H2H) clinical trials for RA, including AMPLE (abatacept vs.

Dr. Evelyn Hess (1925-2015) - Working With and For the Patient

Save

RheumNow sadly notes that rheumatology icon and educator Dr. Evelyn Hess passed away on December 25, 2015.  She leaves behind a legacy career and a legion of clinicians, teachers, researchers and leaders whom she taught and inspired.

FDA Approves Taltz for Psoriasis

Save

Tuesday the FDA approved the IL-17 inhibitor, Taltz (ixekizumab) for adults with moderate to severe plaque psoriasis. (Citation source http://buff.ly/1py10wd)